BioSpace News Archive

Government of Canada investing in $20-million project proposal to launch integrated market

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to accelerate and de-risk drug research and development, today announced their participation at the Immuno-Oncology Summit occurring August 5-9, 2019 in Boston, MA.

Massachusetts Superior Court will address the merits of the complaints filed against Purdue Pharma by Attorney General Maura Healy which Purdue is attempting to have dismissed.

Gift cards made possible thanks to generous Amazon donation to the Red Cross to help save patient lives

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2019 and provided an update on the launch of INGREZZA® (valbenazine) and its clinical development programs.

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today announced its financial and operating results for the second quarter ended June 30, 2019.

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today 510(k) clearance of the PrisMax system and integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE).

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorisation in the European Union (EU).

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that the Company’s shareholders have voted to approve uplisting to a national securities exchange, during its annual shareholder meeting (“meeting”) held on July 24.

Special ticket package includes donation to support prostate cancer research